FDA Eyes Limits on 503B Bulk Substances List
Pharmacy Practice News-8 hours ago
An FDA draft guidance limiting the bulk drug substances that 503B facilities can use in compounding may trigger several unintended consequences, including a .
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, May 22, 2018
USP Compliance Opens Door to Pharmacy Redesign
Pharmacy Practice News-8 hours ago
For some institutions, renovations have been limited to the sterile compoundingspace, but in others, the new guidelines have provided an impetus to take on the.
Subscribe to:
Posts (Atom)